Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.

Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.

Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.